Innovaderm Hires Ina Zschocke to Lead European Operations and Strategy
Canadian CRO Innovaderm is expanding its operations in Europe. The company has appointed Ina Zschocke, Ph.D., as executive vice president of European operations and strategy. This announcement was made on November 19.
Zschocke will lead Innovaderm’s European initiatives and focus on business growth and client service improvement. She has extensive research experience in dermatology, allergology, and aesthetics. Previously, she was vice president of dermatology and corporate strategy at TFS HealthScience. Zschocke also founded SCIderm, a dermatology CRO, and managed it for 15 years before it was acquired by TFS, part of Swedish private equity firm Ratos.
Innovaderm’s CEO, Robert Bissonnette, M.D., expressed excitement about Zschocke’s addition to the team. He highlighted her experience as a significant asset for the company’s growth and focus on rheumatology in Europe.
How will Dr. Ina Zschocke leverage her previous experiences to enhance Innovaderm’s position in dermatology and rheumatology?
Interview with Dr. Ina Zschocke: Innovaderm’s New Executive Vice President of European Operations
News Directory 3: Thank you for joining us, Dr. Zschocke. Can you share what motivated you to take on the role of executive vice president of European operations and strategy at Innovaderm?
Dr. Ina Zschocke: Thank you for having me. The decision to join Innovaderm was an exciting one, primarily due to the company’s strong reputation in dermatology and rheumatology research. I see significant potential for business growth in Europe, and I am eager to leverage my experience to enhance client service and expand our initiatives in this important market.
News Directory 3: You have an impressive background, particularly with your experience at TFS HealthScience and founding SCIderm. How will these experiences inform your approach at Innovaderm?
Dr. Ina Zschocke: My background in managing a dermatology CRO has provided me with insights into both the challenges and opportunities within the industry. At TFS HealthScience, I honed my skills in corporate strategy and developed a keen understanding of client needs. This experience will help me craft tailored strategies that drive growth and improve service delivery to our partners in Europe.
News Directory 3: What specific strategies do you plan to implement as you lead Innovaderm’s European initiatives?
Dr. Ina Zschocke: My focus will be on enhancing our operational capabilities and scaling our services to meet the diverse needs of our clients. I aim to foster stronger relationships with local stakeholders and regulatory bodies, ensuring that we adhere to the highest standards while also being agile in our responses. Additionally, I plan to promote collaboration across our existing European offices to unify our approach and enhance client engagement.
News Directory 3: Innovaderm’s CEO, Dr. Robert Bissonnette, mentioned your experience as a significant asset. How do you see your role contributing to the company’s overall growth strategy, especially in rheumatology?
Dr. Ina Zschocke: I am dedicated to establishing Innovaderm as a leader in rheumatology research across Europe. By building on our foundation in dermatology and expanding our expertise in rheumatological studies, we can fill market gaps and provide clients with unparalleled research capabilities. My immediate goal is to identify areas for innovation within our service offerings and drive strategic partnerships that will bolster our market position.
News Directory 3: As you take on this new challenge, what excites you the most about this opportunity?
Dr. Ina Zschocke: The prospect of working with such a talented team and being part of a company that is committed to advancing research in dermatology and rheumatology truly excites me. I am eager to contribute to Innovaderm’s mission and witness firsthand the positive impact our work can have on patient care and treatment outcomes in Europe.
News Directory 3: Thank you, Dr. Zschocke, for your insights. We look forward to seeing how your leadership will shape Innovaderm’s future in Europe.
Dr. Ina Zschocke: Thank you! I appreciate the opportunity to share my vision, and I am excited about what lies ahead.
Innovaderm is based in Montreal and specializes in dermatology and rheumatology research. The firm currently operates in Canada, the U.S., Spain, and Poland.